“The culture here reminds me of Genentech in the early days. It’s an honor to join the team as a Scientific Advisor,” said Dr. Bennett. “AbSci’s technology is a quantum improvement in bacterial expression systems.”
AbSci announced today the appointment of Fred Larimore, PhD to AbSci’s Scientific Advisory Board. Dr. Larimore brings over 30 years of experience in biopharmaceutical manufacturing and process development at leading pharmaceutical companies …
AbSci, a global leader in breakthrough biomanufacturing technologies, today announced that it is further expanding its offices and laboratory facilities. “We’ve seen a significant increase in partnership deal flow, which is a testament to the innovation and quality of work performed by our scientists,” said CEO and Founder, Sean McClain …
“I wasn’t there when Bill Boeing did his seaplane or when Bill Gates was coming up with software programs. But I’m here,” Inslee told Sean McClain, founder and CEO of AbSci, on Monday.
AbSci announced today that the company has finalized a lease agreement to relocate its headquarters to the new Hudson Building in downtown Vancouver, WA. AbSci expects to begin renovations by the beginning of September, and plans to take occupancy of the state-of-the-art lab facility by Q4 of this year, where the company will continue to develop and commercialize its revolutionary protein production technology.